News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
BioPharmX Corporation Closes Underwritten Public Offering Of Common Stock 7/1/2015
EndoChoice Announces Debt Refinancing 7/1/2015
Zynerba Files Registration Statement For Proposed Initial Public Offering Of Common Stock 7/1/2015
Senomyx, Inc. (SNMX) Announces Continued Inclusion In The Russell 2000 And Russell 3000 Indexes 7/1/2015
Discovery Laboratories (DSCO) Receives Nasdaq Notification Related To Minimum Bid Price 7/1/2015
Dynatronics Corporation (DYNT) Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 7/1/2015
Alder Biopharma Announces Exercise In Full Of Option To Purchase Additional Shares 7/1/2015
Resverlogix (RVX.TO) Shareholders Approve Matters Relating To Licensing And Equity Arrangement 7/1/2015
Conversion Right Extended On Opko Health (OPK) 3.0% Convertible Senior Notes 7/1/2015
EXCLUSIVE: Gene Therapy M&A Booms, Increasing 40-Fold to $4.9 Billion 7/1/2015
Conversion Right Triggered For LabCorp (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021 7/1/2015
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7/1/2015
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7/1/2015
Ignyta (RXDX) Added To Russell 2000 Index 6/30/2015
Change In The Total Number Of Shares And Votes In Recipharm AB 6/30/2015
Change In Number Of Shares Outstanding In Sectra (SECTB) During June 6/30/2015
EnteroMedics (ETRM) Announces Pricing Of $35.0 Million Public Offering Of Common Stock And Warrants 6/30/2015
ViewRay Secures Up To $50M In Debt Financing From CRG 6/30/2015
Inari Medical Announces Closing Of $12.4 Million Venture Financing 6/30/2015
Asterias Biotherapeutics Added To Russell 2000, Russell 3000, Russell Global And Russell Microcap Indexes 6/30/2015
Affimed Therapeutics AG (AFMD) Added To Russell 2000(R) Index 6/30/2015
Agile Therapeutics, Inc. Added To Membership Of Russell 2000, 3000 And Global Indexes 6/30/2015
Alliqua Biomedical (ALQA) To Ring The Nasdaq Stock Market Opening Bell On July 6th 6/30/2015
Isis Pharma (ISIS) Promoted To The Large-Cap Russell 1000 Index 6/30/2015
Webcast Alert: Corporate Presentation At The 2015 Isis Pharma (ISIS) Annual Stockholder Meeting 6/30/2015
Ocata Therapeutics Added To Russell 2000, 3000, Global And Microcap Indices 6/30/2015
Dipexium Pharmaceuticals (DPRX) Announces Closing Of Public Offering Of Common Stock 6/30/2015
Hanger Inc. (Formerly known as Hanger Orthopedic Group, Inc.) (HGR) Announces Senior Notes Consent Solicitation 6/30/2015
Ardelyx (ARDX) To Host Inaugural R&D Investor Day In New York City On July 14, 2015 6/30/2015
Circassia (CIR.L)’s Extended Offer Period For Aerocrine Has Increased Acceptances To 97.2 Percent 6/30/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 6/30/2015
Jaguar Animal Health Added To Russell Microcap Index 6/30/2015
EnteroMedics (ETRM) Announces Proposed Public Offering Of Common Stock And Warrants 6/30/2015
MagForce AG Publishes Financial Year Results 2014 And Operative Highlights 6/30/2015
EXCLUSIVE: Knives Are Out for Biotech, As Bears Snag Options for Bubble Burst 6/29/2015
Profound Medical Announces Annual Meeting of Shareholders Voting Results 6/29/2015
Anthera Pharmaceuticals, Inc. (ANTH) Added To The Russell 2000 And Russell 3000 Indexes 6/29/2015
Fibrocell Science, Inc. Joins the Russell 2000 Index 6/29/2015
Proteon Therapeutics, Inc. (PRTO) Announces Addition To Russell 2000 Index 6/29/2015
ADMA Biologics, Inc. Joins Russell Microcap Index 6/29/2015
Amicus Therapeutics, Inc. (FOLD) Joins Russell 3000 And Russell 2000 Indexes 6/29/2015
HTG Molecular Diagnostics Added To Russell Microcap Index 6/29/2015
CAPNIA, Inc. Added To Russell Microcap Index 6/29/2015
Medgenics, Inc. Added To RUSSELL 3000 And Global Indexes 6/29/2015
NeuralStem Inc. Announces Approval For Listing On The NASDAQ Capital Market 6/29/2015
Contract Research Organization WCCT Global Receives Large Investment From Asian Equity Firm 6/29/2015
InVivo Therapeutics (NVIV) Is Added To Russell Global, Russell 3000, Russell 2000, And Russell Microcap Indexes 6/29/2015
Catalyst Pharmaceuticals (CPRX) Joins Russell 2000, 3000 And Global Indexes 6/29/2015
Blueprint Medicines (BPMC) Added To Russell 2000, 3000 And Global Indexes 6/29/2015
aTyr Pharma Added To Russell 2000, 3000 And Global Indexes 6/29/2015
TrovaGene, Inc. Upgraded To Russell 3000, Small Cap And Global Indexes 6/29/2015
BrainStorm Cell Therapeutics Inc. Added To Russell Microcap Index 6/29/2015
Sorrento Added To Russell 2000 Small Cap, Russell 3000 And Global Indexes 6/29/2015
Trevena, Inc. (TRVN) Added To Russell 3000, Russell 2000, And Russell Global Indexes 6/29/2015
Trimel Pharmaceuticals (TRL.TO) Announces Voting Results For 2015 Annual General And Special Shareholder’s Meeting 6/29/2015
Aerocrine Applies For Delisting 6/29/2015
MYOS (MYOS) Issues Letter To Shareholders Highlighting Key Accomplishments 6/26/2015
Seres Therapeutics Raises $133M for State's Second-Largest Bio IPO, As Rival OpenBiome Grows 6/26/2015
Alder Biopharma Prices Public Offering Of Common Stock 6/26/2015
Concordia Healthcare Corp. Reports Results Of Annual General Meeting Of Shareholders 6/26/2015
CAPNIA, Inc. Announces Commencement Of Series B Warrant Exchange Offer 6/26/2015
Invitation - Presentation Of Sobi's Second Quarter 2015 6/26/2015
NeuroVive Share upgraded On OTC Market In U.S. 6/26/2015
Merck & Co. (MRK) To Hold Second-Quarter 2015 Sales And Earnings Conference Call On July 28 6/26/2015
Sangui BioTech International Inc. (SGBI) Files S-1 Registration Statement With The SEC 6/26/2015
Pfizer (PFE) Declares 28-Cent Third-Quarter 2015 Dividend 6/26/2015
Catabasis Pharmaceuticals, Inc. Shares Surge In Nasdaq Debut; Upsizes to Grab $60M in IPO 6/25/2015
Dipexium Pharmaceuticals (DPRX) Announces Proposed Public Offering Of Common Stock 6/25/2015
IMPAX Labs (IPXL) Announces Private Offering Of Convertible Senior Notes 6/25/2015
Alere (ALR) Announces Completion Of Offering Of $425 Million Of Senior Subordinated Notes 6/25/2015
Dipexium Pharmaceuticals (DPRX) Announces Pricing OF Public Offering Of Common Stock 6/25/2015
Alder Biopharma Announces Commencement Of Public Offering Of Common Stock 6/25/2015
Cesca Therapeutics Announces Compliance With Nasdaq Stock Market Under Listing Rule 5250(c)(1) 6/25/2015
Pluristem Therapeutics (PSTI) Announces Pricing Of Registered Direct Offering Of Common Stock And Warrants 6/25/2015
IMPAX Labs (IPXL) Prices Private Offering Of Convertible Senior Notes 6/25/2015
Skyepharma PLC (SKYEF) Release: Interim Results Pre-close Trading Update 6/25/2015
Concordia Healthcare (CXR.TO) To Commence Trading On NASDAQ Global Select Market Under Symbol "CXRX" 6/25/2015
BioPharmX Uplists To NYSE MKT (BPMX) 6/25/2015
Advaxis, Inc. Provides 2015 Half-Year Review And Outlook 6/25/2015
Generex Biotechnology Corporation (GNBT) Announces Capital Investment 6/25/2015
Provectus Biopharmaceuticals Inc. Announces Closing Of Public Offering 6/25/2015
Portage Biotech Completes Non-Brokered Private Placement In Two Tranches For A Total Proceeds Of US$ 5,155,080 6/25/2015
PBM Capital Group Invests In Xalud Therapeutics Gene Therapy Platform For Treatment Of Neuro-Inflammatory Diseases 6/25/2015
Endo International (ENDP) Announces Pricing Of Private Offering Of Senior Notes 6/24/2015
Jinchi Biotech Ltd. Is Officially Listed On The National Stock Exchange Of Australia 6/24/2015
bluebird bio (BLUE) Announces Proposed Public Offering Of Common Stock 6/24/2015
Epizyme (EPZM) Surges on NHL Cancer Drug Data, As Analysts Laud Early Successes 6/24/2015
Aethlon Medical (AEMD) Announces $6 Million Equity Investment 6/24/2015
Nevro Announces Full Exercise And Closing Of Underwriters' Option To Purchase Additional Shares 6/24/2015
Lion Biotechnologies, Inc. To Join Russell Global Index 6/24/2015
bluebird bio (BLUE) Announces Pricing Of Public Offering Of Common Stock 6/24/2015
PureTech Health plc Admission To Trading On The London Stock Exchange 6/24/2015
BiondVax Pharmaceuticals Announces A Closing Of Over-Allotment Option 6/24/2015
Celyad Announces Closing of Its Global Offering 6/24/2015
Highland Therapeutics Announces Closing Of US$50 Million Financing 6/24/2015
XBiotech Added to Russell 2000 Index 6/24/2015
Medigus (MDGS.TA) - ADR Free Issuance Announcement 6/24/2015
PAREXEL International (PRXL) Issues Earnings Guidance In Conjunction With Investor Day 6/24/2015
Cidara Therapeutics (CDTX) Set To Join Russell Indexes 6/24/2015
Ekso Bionics (EKSO) Files a Shelf Registration Statement With SEC 6/24/2015
Biotech's Growth is White-Hot, But Analysts Urge Caution 6/23/2015
Harvard Bioscience Inc. (HBIO) To Join The Russell 3000 And Russell Global Indexes 6/23/2015
Agenus (AGEN) To Webcast Annual Meeting Of Stockholders 6/23/2015
Medivation, Inc. (MDVN) To Redeem Outstanding Convertible Notes Due 2017 6/23/2015
ADMA Biologics, Inc. Secures Up To $21 Million Loan Commitment From Oxford Finance 6/22/2015
Partek Incorporated Set To Join Russell 3000 And Russell Global Indexes 6/22/2015
Advaxis, Inc. Selected For Inclusion In Russell Global And Russell 3000 Indexes 6/22/2015
Galapagos (GLPG.BR) Raises €4.4 Million Through Warrant Exercises 6/22/2015
BioScrip (BIOS) Announces Completion Of Exchange Offer For Its 8.875% Senior Notes Due 2021 6/22/2015
Perseon Announces Reverse Stock Split Effective June 23, 2015 6/22/2015
Pharmascience Inc. To Invest More Than $55 Million To Upgrade Its R&D And Manufacturing Facilities In Greater Montreal 6/22/2015
Conkwest Files Registration Statement For Proposed Initial Public Offering 6/22/2015
Alexion (ALXN) Accepts Shares Of Synageva BioPharma (GEVA) Tendered Into Exchange Offer 6/22/2015
Provectus Biopharmaceuticals Inc. Announces Proposed Public Offering Of Common Stock And Warrants 6/19/2015
BioScrip (BIOS) Announces Record Date For Rights Offering 6/19/2015
TapImmune Inc. (TPIV) Announces Immediate Infusion of $2.5 Million Dollars From Largest Institutional Investor 6/19/2015
CytoSorbents, Inc. Set To Join Russell Microcap Index 6/19/2015
Zogenix (ZGNX) Announces Shareholders And Board Of Directors Approve Reverse Stock Split 6/19/2015
Endo International (ENDP) Announces Proposed Private Offering Of Senior Notes 6/19/2015
Baxalta Announces Pricing of $5 Billion Private Placement Notes Offering 6/19/2015
Provectus Biopharmaceuticals Inc. Announces Pricing Of Public Offering To Raise $13.1 Million 6/19/2015
VGLS Notes Key Patents, License And Other Major Achievements In The First Half Of 2015 6/19/2015
Nordic Nanovector: NANO – Mandatory Notification Of Trade 6/19/2015
Rock Creek Pharmaceuticals Announces Closing Of Registered Direct Offering 6/19/2015
Abeona Therapeutics, Formerly Known As PlasmaTech Biopharmaceuticals To Ring The Nasdaq Stock Market Closing Bell 6/19/2015
BIO2015: Venture Capitalists Need to Back Off On Questioning Science, Says Vertex (VRTX) Founder 6/18/2015
Organovo Holdings, Inc. Announces Proposed Public Offering Of Common Stock 6/18/2015
AEterna Zentaris (AEZS) Announces Extension To Regain Compliance With NASDAQ's Minimum Bid Price Rule 6/18/2015
Parnell Pharmaceuticals Holdings Announces $11 Million Secured Term Loan Facility 6/18/2015
Amicus Therapeutics, Inc. (FOLD) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Over-Allotment Option 6/18/2015
Supernus Pharmaceuticals (SUPN) Corrects Earlier Statement Regarding Distribution Of Common Stock By NEA 6/18/2015
Organovo Holdings, Inc. Prices $40 Million Public Offering Of Common Stock 6/18/2015
Oculus Innovative Sciences, Inc. (OCLS) Regains Compliance With Nasdaq Minimum Bid Price Rule 6/18/2015
RestorGenex Announces Stockholder Approval Of Reincorporation In Delaware 6/18/2015
Arcadia Biosciences (RKDA) Closes Underwriters’ Option To Purchase Additional Shares 6/18/2015
McKesson Corporation To Webcast Investor Day 6/18/2015
Ocata Therapeutics To Ring The NASDAQ Stock Market Opening Bell On June 24, 2015 6/18/2015
Baxter International (BAX) Announces Debt Tender Offers 6/18/2015
Dr. Reddy's Laboratories Ltd. (RDY) Announces Filing Of Annual Report On Form 20-F 6/18/2015
BIO2015 EXCLUSIVE: DelMar Pharmaceuticals Files for $8M Fund Raise, BioSpace (DHX) Learns 6/17/2015
Supernus Pharmaceuticals (SUPN) Announces Distribution Of Common Stock By NEA 6/17/2015
Rock Creek Pharmaceuticals Announces $3.7 Million Registered Direct Offering 6/17/2015
Kythera (KYTH) Grants Stock Options Under Inducement Program 6/17/2015
Atopix Secures Funding To Broaden Development Of CRTH2 Antagonists For TH2-Mediated Disease 6/17/2015
Fosun Pharma Plans Big Increase In Foreign Drug Revenues 6/17/2015
PAREXEL International (PRXL) Invites Public To Listen To Live Webcast Of Its Investor Day June 24, 2015 6/17/2015
CytoTools And Existing Shareholders Strengthen Successful Subsidiary Dermatools Biotech Gmbh With Capital Increase 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
Ocata Therapeutics Announces Pricing Of $30 Million Offering Of Common Stock And Warrants 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/17/2015
Celgene (CELG) Announces Additional $4 Billion Share Repurchase Authorization 6/17/2015
Orexo AB (ORXOF): Issue And Repurchase Of Class C Shares 6/17/2015
Axovant (AXON) Announces Completion Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/16/2015
Oculus Innovative Sciences, Inc. (OCLS) Announces Sale Of 1.65 Million Shares Of Ruthigen Stock For $4.5 Million In Non-Dilutive Funding 6/16/2015
Cellular Biomedicine Group (CBMG) Selected For Inclusion In The Russell 3000 Index 6/16/2015
Chimerix (CMRX) Announces Exercise In Full Of Option To Purchase Additional Shares Of Common Stock 6/16/2015
Kite Pharma (KITE) To Host Investor Day On June 23, 2015 6/16/2015
Intellirod Spine Raises Capital And Obtains ISO Certification 6/16/2015
Pulmatrix Raises $10 Million Private Placement; To Begin Trading On NASDAQ Under "PULM" 6/16/2015
Ampio Pharmaceuticals, Inc. (AMPE) Provides Information On The Formation And Significance Of Aytu Bioscience To Ampio Shareholders 6/16/2015
NeoGenomics, Inc. (NGNM.OB) Set To Join Russell 3000 Index 6/16/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/16/2015
Isis Pharma (ISIS) To Present A General Corporate Update At Its 2015 Annual Meeting Of Stockholders And Open House 6/16/2015
BioTie Therapies Corp. Announces Closing Of U.S. Public Offering And Conversion Of Convertible Notes 6/16/2015
Corbus Announces Inclusion In Russell MicroCap Index 6/16/2015
EXACT Sciences Corporation (EXAS) To Webcast Investor & Analyst Day 6/16/2015
Skystar Bio-Pharmaceutical (CGPN) Announces Submission Of Plan Of Compliance With Nasdaq 6/16/2015
ProNAi Therapeutics, Inc. Files Registration Statement For Proposed Initial Public Offering 6/15/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6/15/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Voting Results From Its Annual Meeting Of Shareholders 6/15/2015
Preliminary Reconstitutions Of Russell 3000, Russell Global And Russell Microcap Indexes Include Asterias Biotherapeutics 6/15/2015
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 6/15/2015
Zealand Pharma  (ZEAL.CO) Release: Major Shareholder Announcement 6/15/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/15/2015
BioTie Therapies Corp. Release: Notification According To Chapter 9, Section 5 Of The Finnish Securities Markets Act 6/15/2015
Beximco Pharmaceuticals Release: Annual General Meeting Statement 6/15/2015
Heron (HRTX) Closes Underwritten Offering Of Common Stock 6/15/2015
Adocia Is Now Integrated Into The CAC Mid 60 And SBF 120 Indices 6/15/2015
BioInvent (BOVNF): Management's Shareholding After Completion Of The Rights Issue 6/15/2015
AGTC To Host Analyst And Investor Day On June 22, 2015 In New York 6/15/2015
Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On June 19, 2015 At 3:00 P.M. ET 6/15/2015
Enzymotec Announces Annual General Meeting Of Shareholders 6/12/2015
Amicus Therapeutics, Inc. (FOLD) Prices Underwritten Offering Of Common Stock 6/12/2015
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares 6/12/2015
BioTie Therapies Corp. Announces Exercise Of Over-Allotment Option 6/12/2015
Prima Biomed (PRR.AX) Receives A Research Tax Credit Cash Rebate In France 6/12/2015
ContraFect (CFRXU) Announces $20,000,000 Private Placement 6/12/2015
Oramed Pharmaceuticals Inc. (ORMP) Announces Closing Of $5.36 Million Registered Direct Offering 6/11/2015
Endo International (ENDP) Closes Offering Of 27,627,628 Ordinary Shares 6/11/2015
Aptose Biosciences Announces Results Of Annual And Special Meeting Of Shareholders 6/11/2015
BioAtla Receives $30 Million Equity Investment From China-based Investor Group 6/11/2015
Chimerix (CMRX) Prices Public Offering Of Common Stock 6/11/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 6/11/2015
Amicus Therapeutics, Inc. (FOLD) Announces Public Offering Of Common Stock 6/11/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 6/11/2015
BioTie Therapies Corp. Announces Completion Of Pricing Of U.S. Public Offering Of ADSs And Conversion Of Convertible Notes 6/11/2015



//-->